Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Nature Reviews. Urology|December 6, 2017
Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibitionArlene Siefker-Radtke, Brendan Curti
American Journal of Surgery|May 6, 2014
Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomasIan White, Jeanine Fortino, Brendan Curti, et al.
Oncoimmunology|December 25, 2012
Radiation and immunotherapy: Renewed allies in the war on cancerSteven K Seung, Brendan Curti, Marka Crittenden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral bloodEdwin B Walker, William Miller, Daniel Haley, et al.
BMC Cancer|March 10, 2016
GMP-grade α-TEA lysine salt: a 28-Day oral toxicity and toxicokinetic study with a 28-Day recovery period in Beagle dogsBella S Guerrouahen, Tobias Hahn, Zefora Alderman, et al.
Nature Communications|September 29, 2025
Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trialJong Chul Park, Brendan Curti, Marcus Butler, et al.
Oral Oncology|September 12, 2016
Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapyR Bryan Bryan, Michael J Gough, Steven K Seung, et al.
Journal for Immunotherapy of Cancer|May 30, 2020
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanomaBrendan Curti, Marka Crittenden, Steven K Seung, et al.
Journal for Immunotherapy of Cancer|April 22, 2017
Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapyGail D Sckisel, Annie Mirsoian, Christine M Minnar, et al.
Cancer|September 16, 2008
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group studyMichael B Atkins, Jeffrey A Sosman, Sanjiv Agarwala, et al.
Pageof 4